Integra LifeSciences slip on lower-than-expected Q2 forecasts
** Shares of medical technology co Integra LifeSciences
IART.O down 8.80% at $53.66 - set for biggest one-day pct.
loss since March 2020
** Co expects Q2 adj. profit in range $0.75 to $0.79 per
share, below analysts' estimates of $0.85- IBES Refinitiv
** Co also expects Q2 rev. below analysts' estimates
** However, IART's FY results forecast is in-line with
estimates
** Co's shares had fallen 4.57% YTD
(Reporting by Vedant Vinayak Vichare in Bengaluru)
((vedant.vinayakvichare@thomsonreuters.com))
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes